Quantitative proteomic analysis reveals AK2 as potential biomarker for late normal tissue radiotoxicity

BACKGROUND: Biomarkers for predicting late normal tissue toxicity to radiotherapy are necessary to personalize treatments and to optimize clinical benefit. Many radiogenomic studies have been published on this topic. Conversely, proteomics approaches are not much developed, despite their advantages....

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Radiat Oncol
Autori principali: Lacombe, Jérôme, Brengues, Muriel, Mangé, Alain, Bourgier, Céline, Gourgou, Sophie, Pèlegrin, André, Ozsahin, Mahmut, Solassol, Jérôme, Azria, David
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2019
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6688300/
https://ncbi.nlm.nih.gov/pubmed/31399108
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-019-1351-8
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi